SAN FRANCISCO, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Upwave, the leading analytics platform for brand advertising, today announced the appointment…
BERKELEY HEIGHTS, N.J., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"),…
TAMPA, Fla., Nov. 09, 2024 (GLOBE NEWSWIRE) -- IT Nation, a global community of peers, thought leaders, and experts dedicated…
November 09, 2024 10:30 ET | Source: Ultragenyx Pharmaceutical Inc. Phase 1/2 data show improvements across all domains and confirm…
TAMPA, Fla., Nov. 09, 2024 (GLOBE NEWSWIRE) -- IT Nation, a global community of peers, thought leaders, and experts dedicated…
November 08, 2024 09:27 ET | Source: VERSES AI Inc. THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE…
Company announced completed Phase 1 enrollment for SAB-142 with no observation of serum sickness. The company remains on track for…
Conference Call to be held on November 18, 2024, at 5:00 PM EST NEW HAVEN, Conn., Nov. 06, 2024 (GLOBE…
November 04, 2024 02:00 ET | Source: Verona Pharma plc Ohtuvayre™ (ensifentrine) launch recorded Q3 net sales of $5.6 million and October…